Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey: 'QOL Survey in Premenopausal Breast Cancer Patients'
Phase of Trial: Phase IV
Latest Information Update: 20 Oct 2016
Price : $35 *
At a glance
- Drugs Leuprorelin (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- Sponsors Takeda
- 31 Aug 2018 Biomarkers information updated
- 02 Apr 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 13 May 2014 New trial record